For research teamsHelp me find a study
Back to all studies
CompletedNCT01207414

Safety study of two Switch Approaches in schizophrenia

This study is completed in the United States. It is testing two Switch Approaches for schizophrenia.

SchizophreniaDrugFrom 18 Years to 64 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether a digital tool or app may be useful for adults experiencing schizophrenia.

What would participation involve?

Participants may use a digital tool or app, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about whether participation can be remote and what device access is needed, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateAugust 2010
Recruitment status
Completed
Enrollment listed in the registry
501
Sponsor
Novartis
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 64 Years
Official registry ID
NCT01207414
Official title
A 12-week, Randomized, Multi-center, Open-Label, Iloperidone, (12-24 mg/Day), Flexible Dose Study Assessing Efficacy, Safety and Tolerability of Two Switch Approaches in Schizophrenia Patients Currently Receiving Risperidone, Olanzapine or Aripiprazole

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT01207414. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 59 sites
  • Birmingham Psychiatry Pharmaceutical Studies, Inc.
    Birmingham, Alabama
    Site status: Not listed — confirm with the team
  • Comprehensive Neuroscience
    Cerritos, California
    Site status: Not listed — confirm with the team
  • ATP Clinical Research Center, Inc.
    Costa Mesa, California
    Site status: Not listed — confirm with the team
  • Collaborative Neuroscience Network
    Garden Grove, California
    Site status: Not listed — confirm with the team
  • Apostle Clinical Trials, Inc.
    Long Beach, California
    Site status: Not listed — confirm with the team
  • Pacific Health Systems
    National City, California
    Site status: Not listed — confirm with the team
  • Pacific Research Partners
    Oakland, California
    Site status: Not listed — confirm with the team
  • Excell Research, Inc.
    Oceanside, California
    Site status: Not listed — confirm with the team
  • University of California, Irvine
    Orange, California
    Site status: Not listed — confirm with the team
  • CNRI San Diego
    San Diego, California
    Site status: Not listed — confirm with the team
  • Affiliated Research Institute
    San Diego, California
    Site status: Not listed — confirm with the team
  • Artemis Institute for Clinical Research
    San Diego, California
    Site status: Not listed — confirm with the team
  • Neuropsychiatric Research Center of Orange County
    Santa Ana, California
    Site status: Not listed — confirm with the team
  • Viking Clinical Research
    Temecula, California
    Site status: Not listed — confirm with the team
  • Collaborative Neuroscience
    Torrance, California
    Site status: Not listed — confirm with the team
  • The Hospital of Central Connecticut
    New Britain, Connecticut
    Site status: Not listed — confirm with the team
  • Comprenhensive Neuroscience
    Washington D.C., District of Columbia
    Site status: Not listed — confirm with the team
  • Amit K. Vijapura MD & Associates
    Jacksonville, Florida
    Site status: Not listed — confirm with the team
  • Scientific Clinical Research
    North Miami, Florida
    Site status: Not listed — confirm with the team
  • Atlanta Center for Medical Research
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Comprehensive Neuroscience
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Northwest Behavioral Research Center
    Marietta, Georgia
    Site status: Not listed — confirm with the team
  • Carman Research
    Smyrna, Georgia
    Site status: Not listed — confirm with the team
  • Institute for Behavioral Medicine
    Smyrna, Georgia
    Site status: Not listed — confirm with the team
  • Alexian Brothers Center for Mental Health
    Arlington Heights, Illinois
    Site status: Not listed — confirm with the team
  • Rush University Medical Center, Treatment Research Center
    Chicago, Illinois
    Site status: Not listed — confirm with the team
  • University of Illinois at Chicago
    Chicago, Illinois
    Site status: Not listed — confirm with the team
  • AMR - Baber Research, Inc.
    Naperville, Illinois
    Site status: Not listed — confirm with the team
  • Midwest Center for Neurobehavioral Medicine
    Oakbrook Terrace, Illinois
    Site status: Not listed — confirm with the team
  • Louisiana Clinical Research
    Shreveport, Louisiana
    Site status: Not listed — confirm with the team
  • Neurobehavioral Medicine Group, Clinical Trials Division
    Bloomfield Hills, Michigan
    Site status: Not listed — confirm with the team
  • Rochester Center for Behavioral Medicine
    Rochester Hills, Michigan
    Site status: Not listed — confirm with the team
  • Precise Research Centers
    Flowood, Mississippi
    Site status: Not listed — confirm with the team
  • St. Charles Psychiatric Associates - Midwest Research Group
    Saint Charles, Missouri
    Site status: Not listed — confirm with the team
  • Center for Emotional Fitness
    Cherry Hill, New Jersey
    Site status: Not listed — confirm with the team
  • CRI World Wide Clinical Research Company
    Willingboro, New Jersey
    Site status: Not listed — confirm with the team
  • Albuquerque Neuroscience
    Albuquerque, New Mexico
    Site status: Not listed — confirm with the team
  • Neurobehavioral Research
    Cedarhurst, New York
    Site status: Not listed — confirm with the team
  • Comprehensive Neuroscience
    Fresh Meadows, New York
    Site status: Not listed — confirm with the team
  • Division of Psychiatry Research - Zucker Hills Hospital
    Glen Oaks, New York
    Site status: Not listed — confirm with the team
  • Finger Lakes Clinical Research
    Rochester, New York
    Site status: Not listed — confirm with the team
  • Behavioral Medical Research
    Staten Island, New York
    Site status: Not listed — confirm with the team
  • Richmond Behavioral Associates
    Staten Island, New York
    Site status: Not listed — confirm with the team
  • North Coast Clinical Trials
    Beachwood, Ohio
    Site status: Not listed — confirm with the team
  • Neurobehavioral Clinical Research
    Canton, Ohio
    Site status: Not listed — confirm with the team
  • IPS Research Company
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • SP Research, PLLC
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Belmont Center for Comprehensive Treatment
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • CRI Worldwide, LLC - Kirkbride Division
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • Carolina Clinical Trials
    Charleston, South Carolina
    Site status: Not listed — confirm with the team
  • Community Clinical Research, Inc.
    Austin, Texas
    Site status: Not listed — confirm with the team
  • KRK Medical Research
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • FutureSearch Trials
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • InSite Clinical Research
    DeSoto, Texas
    Site status: Not listed — confirm with the team
  • Bayou City Research Limited
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Claghorn-Lesem Research Clinic, Inc
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Mary Ann Knesevich, MD, PA
    Irving, Texas
    Site status: Not listed — confirm with the team
  • InSite Clinical Research
    Plano, Texas
    Site status: Not listed — confirm with the team
  • Frontier Institute
    Spokane, Washington
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving iloperidone. Phase 4 studies usually happen after treatment approval, to monitor real-world use.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 18 Years to 64 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Novartis, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.